Lung Cancer Awareness Month

by ALK+ International

Lung Cancer Awareness Month  by ALK+ International cover photo


raised by 89 donations

of £10,000.00 Target Goal


The Story

November is Lung Cancer Awareness Month. Lung cancer is today the leading cause of cancer death worldwide for both women and men. However, thanks to medical research, even those of us with advanced lung cancer are living longer lives. However, with more research and by working together, we believe we can do even better. This year for Lung Cancer Awareness Month, ALK+ International has partnered with US-based non-profit ALK Positive Inc and developed a social media campaign called “More Research, More Life.” Our social media campaign highlights the unexpected faces and stories of those diagnosed with ALK+ lung cancer. Our goal is to raise £10000, all of which will go straight into our research fund. It is thanks to research that we ALK-positive lung cancer patients are alive today. Through more research, we know that we can increase life expectancy further and even one day find a cure. With your help, we can make this happen even sooner.

ALK+ International

ALK+ International is a patient and family-led charity, created with a single mission: to improve the life expectancy for ALK+ cancer patients. We aim to achieve this by fundraising for ALK+ research, providing grants, advocacy and education. Our team is committed to making a difference and is passionate about our goal. ALK+ cancer is a type of genetic mutation cancer with no known cause, and no known cure once it has spread to other parts of the body. It is caused by a mutation or fusion of the ALK gene. ALK+ cancers are found in patients of all ages, although on average these patients tend to be younger. ALK+ lung cancer occurs in approximately 5% of all non small cell lung cancer patients. However, it occurs in approximately 30% of lung cancer patients diagnosed under age 40. Around half of ALK+ lung cancer patients are diagnosed before the age of 50. It is estimated that there are approximately 100,000 ALK+ lung cancer patients diagnosed worldwide every year. It is estimated that there are more than 10,000 ALK+ lung cancer patients living in the UK. The overall ALK+ figure is likely to be higher, given that ALK+ mutations drive other cancers. Since the discovery of ALK+ cancer in 2007, there have been incredible advances in the range of life saving treatments. As with other cancers linked with genetic mutations, ALK+ cancer is treated with targeted therapies - a class of drugs that precisely target and inhibit cancer cell growth with considerably fewer side effects than traditional treatments. While this makes ALK+ cancer treatable, it is still incurable. ALK+ patients will develop resistance to their medication or experience further mutations, rendering their treatment ineffective. Research is needed into further treatments, to provide either more targeted therapies or diversify treatment options

Lung Cancer Awareness Month : Photos

Lung Cancer Awareness Month : Latest Donations

Anonymous donated £5.00 on 2024/4/17 at 1:46.

Chantal donated £2.00+ £0.50 on 2024/4/16 at 1:46.

Anonymous donated £5.00 on 2024/3/17 at 1:45.

Chantal donated £2.00+ £0.50 on 2024/3/16 at 1:46.

Anonymous donated £5.00 on 2024/2/17 at 1:45.

Chantal donated £2.00+ £0.50 on 2024/2/16 at 1:46.

Anonymous donated £5.00 on 2024/1/17 at 1:45.